Sheng Wei, Ji Guang, Zhang Li
Institute of Digestive Diseases, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Front Pharmacol. 2022 Jul 7;13:910493. doi: 10.3389/fphar.2022.910493. eCollection 2022.
Lithocholic acid (LCA) is a monohydroxy bile acid produced by intestinal flora, which has been found to be associated with a variety of hepatic and intestinal diseases. LCA is previously considered to be toxic, however, recent studies revealed that LCA and its derivatives may exert anti-inflammatory and anti-tumor effects under certain conditions. LCA goes through enterohepatic circulation along with other bile acids, here, we mainly discuss the effects of LCA on the gut-liver axis, including the regulation of gut microbiota, intestinal barrier, and relevant nuclear receptors (VDR, PXR) and G protein-coupled receptor five in related diseases. In addition, we also find that some natural ingredients are involved in regulating the detoxification and excretion of LCA, and the interaction with LCA also mediates its own biological activity.
石胆酸(LCA)是一种由肠道菌群产生的单羟基胆汁酸,已发现其与多种肝脏和肠道疾病有关。LCA以前被认为具有毒性,然而,最近的研究表明,LCA及其衍生物在某些条件下可能发挥抗炎和抗肿瘤作用。LCA与其他胆汁酸一起经历肠肝循环,在此,我们主要讨论LCA对肠-肝轴的影响,包括在相关疾病中对肠道微生物群、肠道屏障以及相关核受体(维生素D受体、孕烷X受体)和G蛋白偶联受体5的调节。此外,我们还发现一些天然成分参与调节LCA的解毒和排泄,并且与LCA的相互作用也介导了其自身的生物学活性。